- Home
- NEO vs EH Comparison
NEO vs EH Comparison
Compare NEO & EH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NEO | EH |
|---|---|---|
| Founded | 2001 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 846.5M |
| IPO Year | 2008 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NEO | EH |
|---|---|---|
| Price | $7.90 | $11.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | $11.14 | ★ $21.85 |
| AVG Volume (30 Days) | ★ 2.0M | 452.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.63 | $10.53 |
| Revenue Next Year | $9.73 | $81.37 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.72 | $11.07 |
| 52 Week High | $13.74 | $25.79 |
Technical Indicators
Market Signals| Indicator | NEO | EH |
|---|---|---|
| Relative Strength Index (RSI) | 19.28 | 46.28 |
| Support Level | $7.07 | $11.15 |
| Resistance Level | $8.89 | $12.80 |
| Average True Range (ATR) | 0.47 | 0.56 |
| MACD | -0.11 | 0.07 |
| Stochastic Oscillator | 2.30 | 34.55 |
Price Performance
Historical ComparisonAbout NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About EH EHang Holdings Limited ADS
EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.